![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Schmid, P.; Cortes, J.; Dent, R.; Pusztai, L.; McArthur, H.; Kummel, S.; Bergh, J.; Denkert, C.; Park, Y. H.; Hui, R.; Harbeck, N.; Takahashi, M.; Untch, M.; Fasching, P. A.; Cardoso, F.; Andersen, J.; Patt, D.; Danso, M.; Ferreira, M.; Mouret-Reynier, M.-A.; Im, S.-A.; Ahn, J.-H.; Gion, M.; Baron-Hay, S.; Boileau, J.-F.; Ding, Y.; Tryfonidis, K.; Aktan, G.; Karantza, V. und O'Shaughnessy, J.
(2022):
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.
In: New England Journal of Medicine, Bd. 386, Nr. 6: S. 556-567
Barbieri, E.; Gion, M.; Mariani, L.; Stieber, P.; Rubino, D.; Fanti, S.; Baum, R.; Wirtz, R.; Bernardi, A.; Cacciari, N.; Quercia, S.; Lenzi, M.; Cubelli, M.; Pizzirani, C.; Carapelle, M.; Pagliaro, M.; Tomasini, S.; Toracchio, S. und Zamagni, C.
(2017):
Three-monthly dynamic evaluation of CEA and CA15-3 and 18-FDG PET vs usual practice in the follow-up of early breast cancer patients: a prospective, multicenter, randomized trial (KRONOS - Patient-Oriented New Surveillance-Study Italy).
In: Annals of Oncology, Bd. 28
Zamagni, C.; Gion, M.; Mariani, L.; Stieber, P.; Quercia, S.; Rubino, D.; Bernardi, A.; Cacciari, N.; Fini, A.; Lenzi, M.; Minichillo, S.; Pizzirani, C.; Pagliaro, M.; Tomasini, S. und Barbieri, E.
(2017):
Three-monthly dynamic evaluation of CEA and CA15-3 (followed by 18-FDG PET) vs usual practice in the follow-up of early breast cancer (BC) patients (pts): A prospective randomized trial (KRONOS-patient-oriented new surveillance study, Italy).
In: Cancer Research, Bd. 77